SEC Form 4 · accession 0001140361-17-008291
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher G Roberts
Director
Period of report
Feb 20, 2017
Accepted (ET)
Feb 21, 2017 · 2:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1,F2 | Feb 20, 2017 | S | 10,000 | $71.91 | D | 313,900 | I | Cabbit Pty Ltd |
| ResMed Common Stock | holding | — | — | — | 145,610 | D | ||
| ResMed Common Stock | holding | — | — | — | 136,000 | I | AceMed Pty Ltd | |
| ResMed Common Stock | holding | — | — | — | 23,200 | I | Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Trade executed as CDI on Australian Securities Exchange converted at 10:1.
- F2ASX sale price average of A$ 9.3715 was converted using the foreign exchange rate on the transaction date of 1 AUD to .76743 USD. Trade was executed in multiple trades ranging in from A$ 9.37 to A$ 9.40 or USD 71.90 to 72.13.